Wells Fargo analyst Yanan Zhu assumes Alaunos Therapeutics (NASDAQ:TCRT) with a Overweight rating and announces Price Target of $3.
Wells Fargo Assumes Alaunos Therapeutics at Overweight, Announces Price Target of $3
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.